Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Imaging genetics in neurodevelopmental psychopathology.

Klein M, van Donkelaar M, Verhoef E, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jul;174(5):485-537. doi: 10.1002/ajmg.b.32542. Review.

PMID:
29984470
2.

Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone.

Wang S, Che T, Levit A, Shoichet BK, Wacker D, Roth BL.

Nature. 2018 Mar 8;555(7695):269-273. doi: 10.1038/nature25758. Epub 2018 Jan 24.

3.

Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder.

Kim JI, Kim JW, Lee JM, Yun HJ, Sohn CH, Shin MS, Kim B, Chae J, Roh J, Kim BN.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:169-176. doi: 10.1016/j.pnpbp.2017.11.018. Epub 2017 Nov 21.

PMID:
29169998
4.

Functional analysis of schizophrenia genes using GeneAnalytics program and integrated databases.

Sundararajan T, Manzardo AM, Butler MG.

Gene. 2018 Jan 30;641:25-34. doi: 10.1016/j.gene.2017.10.035. Epub 2017 Oct 13.

PMID:
29032150
5.

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects.

Gomez-Sanchez CI, Carballo JJ, Riveiro-Alvarez R, Soto-Insuga V, Rodrigo M, Mahillo-Fernandez I, Abad-Santos F, Dal-Ré R, Ayuso C.

Sci Rep. 2017 Sep 4;7(1):10391. doi: 10.1038/s41598-017-10912-y.

6.

Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood.

Kappel DB, Schuch JB, Rovaris DL, da Silva BS, Cupertino RB, Winkler C, Teche SP, Vitola ES, Karam RG, Rohde LA, Bau CHD, Grevet EH, Mota NR.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):120-127. doi: 10.1016/j.pnpbp.2017.06.011. Epub 2017 Jun 15.

7.

Effects of dopamine D2/D3 receptor antagonism on human planning and spatial working memory.

Naef M, Müller U, Linssen A, Clark L, Robbins TW, Eisenegger C.

Transl Psychiatry. 2017 Apr 25;7(4):e1107. doi: 10.1038/tp.2017.56.

8.

Age-dependent role of pre- and perinatal factors in interaction with genes on ADHD symptoms across adolescence.

Brinksma DM, Hoekstra PJ, van den Hoofdakker B, de Bildt A, Buitelaar JK, Hartman CA, Dietrich A.

J Psychiatr Res. 2017 Jul;90:110-117. doi: 10.1016/j.jpsychires.2017.02.014. Epub 2017 Feb 21.

PMID:
28259004
9.

Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.

Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, Booij J, Lucassen PJ, Reneman L.

PLoS One. 2017 Feb 27;12(2):e0172776. doi: 10.1371/journal.pone.0172776. eCollection 2017.

10.

Inattention and Reaction Time Variability Are Linked to Ventromedial Prefrontal Volume in Adolescents.

Albaugh MD, Orr C, Chaarani B, Althoff RR, Allgaier N, D'Alberto N, Hudson K, Mackey S, Spechler PA, Banaschewski T, Brühl R, Bokde ALW, Bromberg U, Büchel C, Cattrell A, Conrod PJ, Desrivières S, Flor H, Frouin V, Gallinat J, Goodman R, Gowland P, Grimmer Y, Heinz A, Kappel V, Martinot JL, Paillère Martinot ML, Nees F, Orfanos DP, Penttila J, Poustka L, Paus T, Smolka MN, Struve M, Walter H, Whelan R, Schumann G, Garavan H, Potter AS.

Biol Psychiatry. 2017 Nov 1;82(9):660-668. doi: 10.1016/j.biopsych.2017.01.003. Epub 2017 Jan 13.

11.

Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.

Robison LS, Ananth M, Hadjiargyrou M, Komatsu DE, Thanos PK.

J Neural Transm (Vienna). 2017 May;124(5):655-667. doi: 10.1007/s00702-017-1680-4. Epub 2017 Jan 23.

12.

The Benefits of Genetic Addiction Risk Score (GARS) Testing in Substance Use Disorder (SUD).

Blum K, Modestino EJ, Gondre-Lewis M, Chapman EJ, Neary J, Siwicki D, Baron D, Hauser M, Smith DE, Roy AK, Thanos PK, Steinberg B, McLaughlin T, Fried L, Barh D, Dunston GA, Badgaiyan RD.

Int J Genom Data Min. 2018;2018(1). pii: 115. doi: 10.29014/IJGD-115.000015. Epub 2018 Jan 15.

13.

D1 and D2 specific dopamine antagonist modulate the caudate nucleus neuronal responses to chronic methylphenidate exposure.

Venkataraman S, Claussen C, Dafny N.

J Neural Transm (Vienna). 2017 Feb;124(2):159-170. doi: 10.1007/s00702-016-1647-x. Epub 2016 Nov 16.

PMID:
27853928
14.

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

Pagerols M, Richarte V, Sánchez-Mora C, Garcia-Martínez I, Corrales M, Corominas M, Cormand B, Casas M, Ribasés M, Ramos-Quiroga JA.

Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.

PMID:
26810137
15.

A Behavioral Genetic Model of the Mechanisms Underlying the Link Between Obesity and Symptoms of ADHD.

Patte KA, Davis CA, Levitan RD, Kaplan AS, Carter-Major J, Kennedy JL.

J Atten Disord. 2016 Jan 21. pii: 1087054715618793. [Epub ahead of print]

PMID:
26794671
16.

High sucrose consumption during pregnancy induced ADHD-like behavioral phenotypes in mice offspring.

Choi CS, Kim P, Park JH, Gonzales EL, Kim KC, Cho KS, Ko MJ, Yang SM, Seung H, Han SH, Ryu JH, Cheong JH, Shin CY.

J Nutr Biochem. 2015 Dec;26(12):1520-6. doi: 10.1016/j.jnutbio.2015.07.018. Epub 2015 Aug 8.

PMID:
26452319
17.

Impulsivity and Concussion in Juvenile Rats: Examining Molecular and Structural Aspects of the Frontostriatal Pathway.

Hehar H, Yeates K, Kolb B, Esser MJ, Mychasiuk R.

PLoS One. 2015 Oct 8;10(10):e0139842. doi: 10.1371/journal.pone.0139842. eCollection 2015.

18.

Age-Dependent D1-D2 Receptor Coactivation in the Lateral Orbitofrontal Cortex Potentiates NMDA Receptors and Facilitates Cognitive Flexibility.

Thompson JL, Yang J, Lau B, Liu S, Baimel C, Kerr LE, Liu F, Borgland SL.

Cereb Cortex. 2016 Dec;26(12):4524-4539. doi: 10.1093/cercor/bhv222. Epub 2015 Sep 23.

PMID:
26405054
19.

NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD.

Mota NR, Rovaris DL, Kappel DB, Picon FA, Vitola ES, Salgado CA, Karam RG, Rohde LA, Grevet EH, Bau CH.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):433-444. doi: 10.1002/ajmg.b.32317. Epub 2015 May 18.

PMID:
25989041
20.

Sibling differences in low birth weight, dopaminergic polymorphisms, and ADHD symptomatology: evidence of GxE.

Jackson DB, Beaver KM.

Psychiatry Res. 2015 Apr 30;226(2-3):467-73. doi: 10.1016/j.psychres.2015.01.025. Epub 2015 Feb 9.

PMID:
25704081

Supplemental Content

Loading ...
Support Center